BPC-157 Capsules deliver Body Protection Compound-157 in oral form; available as standalone BPC-157 or as a combination with TB-500 for enhanced recovery support. The oral formulation is particularly well-suited for gut-focused applications, as BPC-157 is naturally derived from a protein found in gastric juice and retains direct cytoprotective activity along the GI tract when delivered orally. BPC-157 is also available as an injectable for systemic or injury-targeted applications. Available in 30 and 60-count formulations.

BPC-157 originates from a gastric cytoprotective protein; its protective and regenerative mechanism was naturally developed for the GI tract. When taken orally, it travels in direct contact with the gastrointestinal lining from ingestion through absorption; exerting protective and epithelial repair activity along the full length of the GI system rather than arriving through systemic circulation after processing elsewhere. For patients whose primary goals involve gut lining integrity, gastrointestinal barrier support, or GI inflammatory management specifically, the oral route provides more direct delivery to the tissue of interest.

RegenMD's BPC-157 Capsules are available as a combination formulation with TB-500; a peptide that promotes tissue repair through actin regulation and systemic cell migration. BPC-157's vascular repair, GI healing, and neurochemical modulation are complemented by TB-500's systemic tissue regeneration and anti-fibrotic activity. The combination is most relevant for patients with overlapping goals of gastrointestinal healing and broader connective tissue or musculoskeletal recovery; the two compounds address distinct aspects of the healing process and work synergistically across those needs.